- Home
- INSW vs RXRX Comparison
INSW vs RXRX Comparison
Compare INSW & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSW | RXRX |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | INSW | RXRX |
|---|---|---|
| Price | $54.16 | $4.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $48.00 | $8.00 |
| AVG Volume (30 Days) | 491.9K | ★ 23.2M |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | ★ 6.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.39 | N/A |
| Revenue | ★ $770,036,000.00 | $43,689,000.00 |
| Revenue This Year | N/A | $6.74 |
| Revenue Next Year | $4.22 | $34.31 |
| P/E Ratio | $11.04 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.20 | $3.79 |
| 52 Week High | $55.18 | $12.36 |
Technical Indicators
Market Signals| Indicator | INSW | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 67.61 | 60.38 |
| Support Level | $46.09 | $4.05 |
| Resistance Level | $49.45 | $4.43 |
| Average True Range (ATR) | 1.48 | 0.25 |
| MACD | 0.41 | 0.06 |
| Stochastic Oscillator | 98.66 | 85.42 |
Price Performance
Historical ComparisonAbout INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.